Company Overview and News
Netflix – Netflix reported quarterly profit of 89 cents per share, easily beating the consensus estimate of 68 cents a share. Revenue was in line with Street forecasts, and the important metric of net subscriber additions was well above analysts' expectations for the video streaming service.
HD XKE GEC GE DB GNE DAL
Target Corp will dedicate nearly a quarter of a million square feet of new space to its toy business across 500 of its stores, the retailer said on Tuesday, part of an effort to win more holiday sales.
Family fashion chain Fat Face has poached the boss of Oasis and Warehouse to become its new chief executive.
NEW YORK, Oct 16 — The real estate investment trusts that own the malls and shopping centres where many Sears stores are anchor tenants have waited years for the retailer's demise to renovate the sites and boost rent, although redevelopment costs may strain some plans.
XKE SHLD BONTQ SPG SHLDW BONT KIM MAC
Sears, the iconic US department store chain, has filed for bankruptcy as it struggles with $5.6bn (£4.3bn) of debt and the relentless march of online shopping.
NEW YORK (Reuters) - The real estate investment trusts that own the malls and shopping centers where many Sears stores are anchor tenants have waited years for the retailer’s demise to renovate the sites and boost rent, although redevelopment costs may strain some plans.
XKE SHLD BONTQ SPG SHLDW BONT KIM MAC
In this photo, taken July 8, 2017, people walk into a Sears store slated for closing that is next to a mall that is being torn down in Overland Park, Kansas. Sears has filed for Chapter 11 bankruptcy protection Monday, Oct. 15, 2018, buckling under its massive debt load and staggering losses. The company once dominated the American landscape, but whether a smaller Sears can be viable remains in question.
SHLD HD XKE BONTQ SHLDW BONT
NEW YORK (AP) — The Latest on the filing for bankruptcy protection by the Sears Holding Corp. (all times local):
More than a year after announcing it was closing all its stores in Canada, Sears has filed for Chapter 11 bankruptcy protection in the U.S., buckling under its massive debt load and staggering losses.
HD XKE BONTQ SCC BONT SRSCQ SRSC
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
as of ET